These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 39398811)

  • 1. Confounding Factors in the Association Between Glucagon-Like Peptide-1 Receptor Agonist Use and Retained Gastric Contents in Asymptomatic Patients Undergoing Upper Gastrointestinal Endoscopy: A Retrospective Study.
    Elimihele TA; Mangrola AM; Oshomoji O; Wilson NB; Nnamani I; Ashong B; Billings S; Getu DK; Kumar S; Maliakkal B
    Cureus; 2024 Sep; 16(9):e69152. PubMed ID: 39398811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-World Impact of GLP-1 Receptor Agonists on Endoscopic Patient Outcomes in an Ambulatory Setting: A Retrospective Study at a Large Tertiary Center.
    Robalino Gonzaga E; Farooq A; Mohammed A; Chandan S; Fawwaz B; Singh G; Malik A; Zhang Y; Kadkhodayan K
    J Clin Med; 2024 Sep; 13(18):. PubMed ID: 39336890
    [No Abstract]   [Full Text] [Related]  

  • 3. Association of glucagon-like peptide receptor 1 agonist therapy with the presence of gastric contents in fasting patients undergoing endoscopy under anesthesia care: a historical cohort study.
    Wu F; Smith MR; Mueller AL; Klapman SA; Everett LL; Houle T; Kuo B; Hobai IA
    Can J Anaesth; 2024 Jul; 71(7):958-966. PubMed ID: 38485835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucagon-Like Peptide-1 Receptor Agonist Use and Residual Gastric Content Before Anesthesia.
    Sen S; Potnuru PP; Hernandez N; Goehl C; Praestholm C; Sridhar S; Nwokolo OO
    JAMA Surg; 2024 Jun; 159(6):660-667. PubMed ID: 38446466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is it necessary to stop glucagon-like peptide-1 receptor agonists prior to endoscopic procedure? A retrospective study.
    Ghazanfar H; Javed N; Qasim A; Sosa F; Altaf F; Khan S; Mahasamudram J; Jyala A; Kandhi SD; Shin D; Mantri N; Sun H; Hanumanthu S; Patel H; Makker J; Balar B; Dev A; Chilimuri S
    World J Gastroenterol; 2024 Jul; 30(26):3221-3228. PubMed ID: 39086638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of Aspiration Pneumonitis After Elective Esophagogastroduodenoscopy in Patients on Glucagon-Like Peptide-1 Receptor Agonists.
    Al Sakka Amini R; Ismail AS; Al-Aqrabawi M; Aleyadeh W; Mohammed A; Altork N; Abosheaishaa H; Elfert KA; Goble SR; Sawaf B; Chandan S
    Cureus; 2024 Aug; 16(8):e66311. PubMed ID: 39238749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of glucagon-like peptide-1 receptor agonists on endoscopy outcomes: A systematic review & meta-analysis.
    Singh S; Rahman SH; Khan N; Rajagopal A; Shafique N; Tawde P; Bhardwaj V; Suresh Kumar VC; Aswath G; Inamdar S; Dutta S; Hurairah A; Mohan BP
    Gastrointest Endosc; 2024 Oct; ():. PubMed ID: 39401599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Consequences of Delayed Gastric Emptying With GLP-1 Receptor Agonists and Tirzepatide.
    Jalleh RJ; Plummer MP; Marathe CS; Umapathysivam MM; Quast DR; Rayner CK; Jones KL; Wu T; Horowitz M; Nauck MA
    J Clin Endocrinol Metab; 2024 Oct; ():. PubMed ID: 39418085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between perioperative semaglutide use and residual gastric content: A retrospective analysis of patients undergoing elective upper endoscopy.
    Silveira SQ; da Silva LM; de Campos Vieira Abib A; de Moura DTH; de Moura EGH; Santos LB; Ho AM; Nersessian RSF; Lima FLM; Silva MV; Mizubuti GB
    J Clin Anesth; 2023 Aug; 87():111091. PubMed ID: 36870274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency of GLP-1 receptor agonists use in diabetic patients diagnosed with delayed gastric emptying and their demographic profile.
    Kalas MA; Dang TQ; Galura G; Alvarado L; Dwivedi AK; Deoker A; McCallum R
    J Investig Med; 2023 Jan; 71(1):11-16. PubMed ID: 36198436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retained Gastric Contents After Adequate Fasting Associated with GLP-1 Receptor Agonist Use: A Report of 3 Cases.
    Kittner SL; Talbott AL; Vishneski SR; Narbaiza J; Shields JS
    JBJS Case Connect; 2023 Oct; 13(4):. PubMed ID: 37943967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Outcomes and Safety of Upper Endoscopy While on Glucagon-Like Peptide-1 Receptor Agonists.
    Firkins SA; Yates J; Shukla N; Garg R; Vargo JJ; Lembo A;
    Clin Gastroenterol Hepatol; 2024 Apr; ():. PubMed ID: 38574832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucagon-Like Peptide-1 Receptor Agonists Increase Solid Gastric Residue Rates on Upper Endoscopy Especially in Patients With Complicated Diabetes: A Case-Control Study.
    Garza K; Aminpour E; Shah J; Mehta B; Early D; Gyawali CP; Kushnir V
    Am J Gastroenterol; 2024 Jun; 119(6):1081-1088. PubMed ID: 38534127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of GLP-1 Receptor Agonists in Gastrointestinal Endoscopy: An Updated Review.
    Singh S; Chandan S; Dahiya DS; Aswath G; Ramai D; Maida M; Anderloni A; Muscatiello N; Facciorusso A
    J Clin Med; 2024 Sep; 13(18):. PubMed ID: 39337114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RA) on Food Content During Esophagogastroduodenoscopy (EGD).
    Stark JE; Cole JL; Ghazarian RN; Klass MJ
    Ann Pharmacother; 2022 Aug; 56(8):922-926. PubMed ID: 34726082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anesthesia Considerations for a Patient on Semaglutide and Delayed Gastric Emptying.
    Fujino E; Cobb KW; Schoenherr J; Gouker L; Lund E
    Cureus; 2023 Jul; 15(7):e42153. PubMed ID: 37602101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safe Continuation of Glucagon-like Peptide 1 Receptor Agonists at Endoscopy: A Case Series of 57 Adults Undergoing Endoscopic Sleeve Gastroplasty.
    Maselli DB; Lee D; Bi D; Jirapinyo P; Thompson CC; Donnangelo LL; McGowan CE
    Obes Surg; 2024 Jul; 34(7):2369-2374. PubMed ID: 38753265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantified Metrics of Gastric Emptying Delay by Glucagon-Like Peptide-1 Agonists: A Systematic Review and Meta-Analysis With Insights for Periprocedural Management.
    Hiramoto B; McCarty TR; Lodhia NA; Jenkins A; Elnaiem A; Muftah M; Flanagan R; Chan WW
    Am J Gastroenterol; 2024 Jun; 119(6):1126-1140. PubMed ID: 38634551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of glucagon-like peptide-1 receptor agonists on gastric mucosal visibility and retained gastric contents during EGD.
    Chapman MB; Norwood DA; Price C; Abdulhadi B; Kyanam Kabir Baig K; Ahmed AM; Peter S; Routman JS; Sánchez-Luna SA; Duggan EW; Mulki R
    Gastrointest Endosc; 2024 Nov; 100(5):923-927. PubMed ID: 38759761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Should We Stop Glucagon-Like Peptide-1 Receptor Agonists Before Surgical or Endoscopic Procedures? Balancing Limited Evidence With Clinical Judgment.
    Umpierrez G; Pasquel FJ; Duggan E; Galindo RJ
    J Diabetes Sci Technol; 2024 Mar; ():19322968241231565. PubMed ID: 38465586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.